Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland

Total article views   HTML views PDF downloads Totals
10,131 Dovepress* 9,414+ 1,470 10,884
PubMed Central* 717 253 970
Totals 10,131 1,723 11,854
*Since 10 April 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar